Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals

Title
Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals
Authors
Keywords
Complement, Drug targeting, Immunogenicity, Liposomes, Nanomedicines, Pharmacokinetics, Biologicals, Hypersensitivity reactions, C activation-related pseudoallergy (CARPA), Adverse drug reactions (ADRs), Anti-drug antibodies, Accelerated blood clearance (ABC)
Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2020-08-01
DOI
10.1016/j.addr.2020.07.024

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search